SynAct Pharma AB Statistics

Total Valuation

FRA:8F8 has a market cap or net worth of EUR 98.49 million. The enterprise value is 93.61 million.

Market Cap	98.49M
Enterprise Value	93.61M

Important Dates

The last earnings date was Wednesday, February 18, 2026.

Earnings Date	Feb 18, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	53.12M
Shares Outstanding	n/a
Shares Change (YoY)	+28.94%
Shares Change (QoQ)	+0.80%
Owned by Insiders (%)	11.38%
Owned by Institutions (%)	10.57%
Float	31.63M

Valuation Ratios

PE Ratio	n/a
Forward PE	5.26
PS Ratio	n/a
PB Ratio	6.26
P/TBV Ratio	6.26
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-9.14
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.31, with a Debt / Equity ratio of 0.01.

Current Ratio	3.31
Quick Ratio	3.10
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-47.55

Financial Efficiency

Return on equity (ROE) is -57.65% and return on invested capital (ROIC) is -37.59%.

Return on Equity (ROE)	-57.65%
Return on Assets (ROA)	-29.67%
Return on Invested Capital (ROIC)	-37.59%
Return on Capital Employed (ROCE)	-58.56%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-1.28M
Employee Count	8
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-754,469
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +19.66% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+19.66%
50-Day Moving Average	1.94
200-Day Moving Average	1.80
Relative Strength Index (RSI)	45.12
Average Volume (20 Days)	11

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-10.77M
Pretax Income	-11.00M
Net Income	-10.24M
EBITDA	n/a
EBIT	-10.77M
Earnings Per Share (EPS)	-0.20

Full Income Statement

Balance Sheet

The company has 4.93 million in cash and 111,900 in debt, with a net cash position of 4.82 million.

Cash & Cash Equivalents	4.93M
Total Debt	111,900
Net Cash	4.82M
Net Cash Per Share	n/a
Equity (Book Value)	15.74M
Book Value Per Share	0.30
Working Capital	4.60M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-8.99M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FRA:8F8 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-28.94%
Shareholder Yield	-28.94%
Earnings Yield	-10.40%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2